Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2008
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1423154B1 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments
11/12/2008EP1259615B1 Antibodies against eotaxin and their use
11/12/2008EP0944647B1 Submucosa extracts
11/12/2008CN101305017A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
11/12/2008CN101304984A Oxazole and thiazole ppar modulator
11/12/2008CN101304747A Combinations comprising a VEGF receptor inhibitor and a penetration enhancer
11/12/2008CN101304732A Controlled release pharmaceutical compositions comprising a fumaric acid ester
11/12/2008CN101304726A Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of anhydrohexitol and of an aliphatic carboxylic acid
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101301462A Decoction for treating cold urticaria
11/12/2008CN101301461A Medicament for treating urticaria
11/12/2008CN101301457A External-use liquid medicine for preventing and treating kibe
11/12/2008CN101301445A External-use powder for treating dermatopathy and paralysis
11/12/2008CN101301442A Decoction for treating papulopustular type acne
11/12/2008CN101301437A Medicinal composition for treating onychomycosis and tinea manuum
11/12/2008CN101301421A Pasty medicament for treating oxter bromidrosis
11/12/2008CN101301419A Composition of paste and powder for psoriasis
11/12/2008CN101301415A External-use medicament for treating pubic phthiriasis
11/12/2008CN101301400A Camellia functional instant formulation and preparation thereof
11/12/2008CN101301393A Externally used Chinese medicine preparation for treating skin of head
11/12/2008CN101301368A Medicinal liquor for treating comedo
11/12/2008CN101301367A Medicament for treating skin disease and preparation thereof
11/12/2008CN101301363A Decoction for treating furuncle
11/12/2008CN101301355A Oil composition containing 1,8-cineole and flavanones extracted from Litsea lancilimba Merr. and Blumea Balsamifera DC. And use thereof
11/12/2008CN101301354A Externally used medicinal liquor for treating psoriasis
11/12/2008CN101301350A Lamioplomis rotate extract oral freeze-dried tablet and preparation thereof
11/12/2008CN101301345A Burn treating medicine
11/12/2008CN101301344A Oral Chinese medicine for treating blood-heat drug induced dermatitis
11/12/2008CN101301342A Soaking medicament for treating hyperkeratotic tinea manuum and tinea pedis
11/12/2008CN101301341A Decoction for treating acute eczema
11/12/2008CN101301336A Decoction medicament for treating localized neurodermatitis
11/12/2008CN101301328A Medicament for treating pyogenic skin infection and carbuncle-abscess
11/12/2008CN101301312A Beriberi medicament and preparation thereof
11/12/2008CN101301299A Medicament composition and use thereof in preparing antimicrobial medicament
11/12/2008CN101301297A Skin photoaging prophylactic agent
11/12/2008CN101301296A Compound preparation for treating beriberi and production method
11/12/2008CN100432226C Small interference RNA molecule inhibiting human papillomavirus II and its application
11/12/2008CN100432220C Keratinocytes which may be used as biologically active substances for the treatment of wounds
11/12/2008CN100432077C N-sulfonylaminothiazole
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432051C Coupling product between tryptamine and alpha-amino acid, process for its prepn. as well as its application in neurocosmetic field
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431582C Extraction process of aloe gel concentrate
11/12/2008CN100431419C Biological agent for foot disinfection
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449559 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449201 Storage stable power compositions of interleukin-4 receptor
11/11/2008US7449177 administering to gamma-interferon, in combination with antihistamines, antiallergens, corticosteroids or mixtures, for the treatment of autoimmune skin diseases; suppression of chemotaxis and function of eosinophils
11/07/2008CA2588942A1 The original sheridan cecil spicer scalpe loosers and scalpe healing hair restoration solution and healthy haire management system
11/06/2008WO2008133330A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008132950A1 External preparation for skin and external preparation for lips
11/06/2008WO2008132729A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008WO2008132458A1 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods
11/06/2008WO2008131936A2 Highly stable electrolytic water with reduced nmr half line width
11/06/2008WO2008131586A1 Uses of 5-methyl-1-(substituted phenyl)-2(1h)-pyridones as anti-inflammatory and tnf-alpha-blocking agents
11/06/2008WO2008104941A3 Personalcare composition comprising botanical extract of ficus benghalensis
11/06/2008WO2008087348A3 Emulsion comprising at least one retinoid and benzoyl peroxide
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
11/06/2008US20080275079 M3 Muscarinic Acetylcholine Receptor Antagonists
11/06/2008US20080275077 Pharmaceutical formulations comprising an immune response modifier
11/06/2008US20080275074 Anti-Itching Agent
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275014 Topical applying a corticoid to human skin
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080274999 Cosmetics; low molecular weight; therapy for osteoarthritis
11/06/2008US20080274468 Novel means for the diagnosis and therapy of ctcl
11/06/2008US20080274204 For bath/body cosmetics; psoriasis, psoriatic arthritis, rheumatoid arthritis, osteoarthritis
11/06/2008US20080274184 Extracellular matrix (ECM) combined with therapeutic agents; promoting tissue wound healing; reducing side effects
11/06/2008US20080274169 Flexible, penetrating liposomal carrier system; bilayer of phospholipids, a hydrophobic photosensitizer, skin penetration enhancers; penetrating through an intact stratum corneum or wound surface without removal of photosensitizer from bilayer without agglomeration of bilayers
11/06/2008US20080274165 Wound healing compositions containing keratin biomaterials
11/06/2008US20080274079 Using mifepristone, cacl2, and/or metyrapone as therapeutic antagonist in treatment of skin disorders; wound healing agents; antiscarring agents
11/06/2008US20080274054 Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008CA2685534A1 Use of matrix metalloproteinase inhibitors in skin care
11/06/2008CA2685131A1 Stable solid preparation containing 4,5-epoxymorphinan derivative
11/06/2008CA2684065A1 Highly stable electrolytic water with reduced nmr half line width
11/06/2008CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1988083A1 Triazole derivative
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1987826A1 Medicine and functional food for controlling or relieving itching and inflammation
11/05/2008EP1987817A2 Pharmaceutical composition of microspheres for preventing diabetic foot amputation
11/05/2008EP1987811A1 Skin-whitening cosmetic
11/05/2008EP1987054A1 Purification and use of a factor for supporting wound healing
11/05/2008EP1986750A2 Use of protoberberines as an active substance regulating the pilosebaceous unit
11/05/2008EP1986691A2 Antimicrobial formulations comprising a quinone and a copper salt
1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 1065